Dr. Frank Borriello to speak at Gamma Delta T Therapies Summit.

July 28, 2022 in Boston.

July 27, 2022.

Alloplex’s Founder and CEO, Dr. Frank Borriello, will be speaking at the 3rd Gamma Delta T Therapies Summit on Thursday 28th July 2022 at 11 AM in a session titled “Reviewing the clinical safety and efficacy of gamma delta therapies” on the Response in Solid Tumors of Non-Engineered Autologous Multi-Cell Therapy.

Synopsis of Dr. Borriello’s presentation:

Outlining the genesis of a multimodal cellular therapy called SUPLEXA
Investigating the clinical mechanism of action of multi-modal cellular therapy in coordinating an anti-tumor response
Developing an exploratory research program with clinical samples to study this autologous therapy
Outlining the clinical observations to date.

Our CSO, Dr. James Lederer, also presented at the pre-conference deep dive day on the 26^th on the topic ‘Studying the Mechanisms of Action of Polyfunctional Gamma Delta T Cells’. By all reports, it’s an excellent meeting with great ideas circulating and lots to learn.

“Clearly Gamma T cells have a lot of promise as an anti-tumor therapy and we are glad to be part of the effort to assess this clinical activity”, Dr. Borriello commented.